Figure 7.
Figure 7. C/EBPα overexpression in Kasumi-1 cells upregulates pathways repressed in primary t(8;21) samples. (A-B) GSEA based on RNA-seq of Kasumi1 after overexpression of C/EBPα. Enrichment of genes that are upregulated in this process in comparison with genes that are repressed in primary t(8;21) as compared with normal karyotype AML samples in both the (A) Verhaak et al cohort52 and (B) The Cancer Genome Atlas (TCGA) cohort53 of patients with AML. (C-D) Model of the C/EBPα-mediated override of t(8;21) and t(3;21) AML transcriptional networks. (C) t(3;21) and t(8;21) AML are epigenetically different AMLs, but (D) overexpression of C/EBPα results in upregulation (blue lines) of myeloid differentiation genes, which also become bound by the fusion proteins, and repression (red lines) of select genes required for stem cell function.

C/EBPα overexpression in Kasumi-1 cells upregulates pathways repressed in primary t(8;21) samples. (A-B) GSEA based on RNA-seq of Kasumi1 after overexpression of C/EBPα. Enrichment of genes that are upregulated in this process in comparison with genes that are repressed in primary t(8;21) as compared with normal karyotype AML samples in both the (A) Verhaak et al cohort52  and (B) The Cancer Genome Atlas (TCGA) cohort53  of patients with AML. (C-D) Model of the C/EBPα-mediated override of t(8;21) and t(3;21) AML transcriptional networks. (C) t(3;21) and t(8;21) AML are epigenetically different AMLs, but (D) overexpression of C/EBPα results in upregulation (blue lines) of myeloid differentiation genes, which also become bound by the fusion proteins, and repression (red lines) of select genes required for stem cell function.

Close Modal

or Create an Account

Close Modal
Close Modal